Legal framework of antimicrobial stewardship in hospitals (LEASH): a European Society of Clinical Microbiology and Infectious Diseases (ESCMID) cross-sectional international survey

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • the LEASH Study Group on behalf of ESCMID Study Group for Antimicrobial StewardshiP (ESGAP) - (Autor:in)
  • Klinische Infektiologie
  • University of Ljubljana
  • ESCMID Study Group for Antimicrobial Stewardship (ESGAP)
  • Université de Lorraine
  • Université de Bordeaux
  • Regional Centre for Prevention of Healthcare Associated Infections
  • Université Laval
  • CHU de Poitiers
  • Hasselt University
  • Maribor Higher Court
  • Università degli Studi di Trieste
  • Universitätsklinikum Carl Gustav Carus Dresden

Abstract

Antimicrobial stewardship (AMS) is the cornerstone activity in the combat against antimicrobial resistance. In order to ensure sustainable deployment and development of AMS, a strategic and regulatory framework needs to be provided by national healthcare authorities. Experts from 32 European countries, Israel and Turkey were invited to participate in a cross-sectional internet-based survey from October 2016 to May 2017 on the legal framework and mandatory components (structures, activities) of AMS in hospitals, i.e. components required by legislation or regulations. We collected data from 25 countries and two regions (in countries with federal health administration). Laws regulating AMS existed in seven countries and one region. Other health ministry regulations were applicable in 13 countries and one region. National strategies and/or action plans approved by ministries of health were in place in 13 countries and one region. Conversely, five countries and one region had no regulation of AMS in hospitals. Funding for AMS in hospitals was provided in five countries and one region. Eight countries and one region reported mandatory AMS structures and activities complying with the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) structure, policy and practice indicators. In 10/27 cases, however, the mandatory AMS activities were not being fully carried out. The survey showed heterogeneous legal frameworks for AMS in hospitals, and in many countries it was even lacking. The situation may be critical in countries with poor control of antimicrobial use and resistance. Recent international initiatives calling on policy-makers to address the threat of antimicrobial resistance could yield improvement.

Details

OriginalspracheEnglisch
Seiten (von - bis)616-621
Seitenumfang6
FachzeitschriftInternational Journal of Antimicrobial Agents
Jahrgang52
Ausgabenummer5
PublikationsstatusVeröffentlicht - Nov. 2018
Peer-Review-StatusJa

Externe IDs

PubMed 30064000
ORCID /0000-0001-9473-3018/work/148606211

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • Antimicrobial stewardship, Europe, Hospitals, Legislation, Strategy